default author photo

Janmejay Singh

Government of India - Vaccine and Infectious Disease Research Center

Patna, Bihar 121001

India

  • Government of India - Vaccine and Infectious Disease Research Center

SCHOLARLY PAPERS

1

DOWNLOADS

169

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Downloads 169 (444,808)

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Number of pages: 48 Posted: 09 Mar 2022
Subhash Thuluva, Vikram Paradkar, Kishore Thuraga, Subbareddy Gunneri, Vijay Yerroju, Rammohanreddy Mogulla, Mahesh Kyasani, Senthilkumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Chandramani Singh and Venkateshwar Rao A
Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Vaccine and Infectious Disease Research Center, Government of India - Vaccine and Infectious Disease Research Center, All India Institute of Medical Sciences (AIIMS), Bhopal and St. Theresa s Hospital - Department of General Medicine
Downloads 93 (732,131)

Abstract:

Loading...

COVID-19, Vaccine, Receptor Binding Domain, SARS-CoV-2, Spike protein, Protein subunit

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit COVID19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Number of pages: 50 Posted: 11 Mar 2022
Subhash Thuluva, Vikram Paradkar, Kishore Thuraga, Subbareddy Gunneri, Vijay Yerroju, Rammohanreddy Mogulla, Mahesh Kyasani, Senthilkumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, CM Singh and Venkateshwar Rao A
Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Vaccine and Infectious Disease Research Center, Government of India - Vaccine and Infectious Disease Research Center, All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine and St. Theresa s Hospital - Department of General Medicine
Downloads 76 (840,816)

Abstract:

Loading...

COVID-19, Vaccine, Receptor binding domain, SARS-CoV-2, Spike protein, Protein subunit